Research reading framework
A public, educational framework for reading study context, uncertainty, evidence limits, and future record relationships. It is not a clinical guideline, a treatment tool, or a formal evidence-certainty assessment.
Evidence hierarchy
Peptide Index adapts broad evidence-reading principles into a transparent editorial taxonomy. It does not claim that every topic has undergone a full GRADE review. Study type is only one part of context; methods, population, endpoints, uncertainty, and replication matter too.
Systematic reviews, meta-analyses, and formal evidence syntheses can explain how a body of research was assembled and assessed.
Read with: Check the review question, included studies, methods, funding context, and whether conclusions reflect the underlying evidence.
Limit: A synthesis is not automatically a recommendation, and Peptide Index does not conduct formal GRADE assessments.
Randomized or otherwise controlled human studies can address defined questions in defined populations under specific protocols.
Read with: Read the population, comparator, measured outcomes, follow-up period, exclusions, and study limitations together.
Limit: A study result does not establish suitability, safety, availability, or an expected outcome for any individual.
Observational studies and small early-stage human research can identify signals and questions for further study.
Read with: Look for selection limits, outcome definitions, confounding, sample size, and whether replication exists.
Limit: Association, an early signal, or a small sample does not establish cause, effectiveness, or a treatment decision.
Cell, tissue, animal, receptor, and mechanism research can help frame biological questions and translational gaps.
Read with: Separate the experimental model from human evidence and note the dose, route, model, and endpoint studied.
Limit: Preclinical findings do not establish a human health effect, product claim, or clinical use.
Some topics have fragmented, indirect, unpublished, or unavailable research that does not support a reliable conclusion.
Read with: Treat the missing evidence as information: identify what has not been studied, reported, replicated, or independently reviewed.
Limit: Absence of a listed study is not proof of absence, safety, effectiveness, quality, or availability.
Future record standard
This is an intake and publishing model, not a vendor list. It exists to keep future coverage attributable, useful, and limited to what the retained record can actually support.
A potential record begins with an attributable public identity and canonical destination. No score, quality claim, or vendor endorsement is implied at intake.
The Editorial Desk records which public source types can support a future reference record, such as methodology context, documentation context, correction history, or dated listing observations.
A page is considered only when enough attributable information exists to answer a distinct user question without filling missing fields with assumptions.
Published records state their source date, limits, and linked methodology. A missing document, product detail, or historical observation remains missing rather than inferred.
Material corrections are logged against Peptide Index’s own record. Publication does not certify a vendor, product, laboratory, price, availability, or transaction outcome.
Knowledge relationships
The relationship model connects each kind of record to the next useful educational or methodological context, rather than creating isolated pages or repetitive keyword links.
Central compound records connect to source-backed evidence profiles where a distinct topic has enough published context for a dedicated educational page.
Browse the research libraryEducational profiles link to public regulatory and trial-discovery context instead of making product, prescribing, or availability claims.
Read Health Canada contextTesting terminology connects to document-reading guidance and current documentation-context records with stated authentication limits.
Read testing-document guidanceControlled vendor records link score context, dated observations, corrections, and methodology without converting limited source facts into product recommendations.
Read the scoring methodologySources and limits
These public sources inform how the framework describes evidence assessment and trial discovery. They do not endorse Peptide Index content or turn this framework into clinical guidance.
Background on structured certainty-of-evidence assessment in evidence syntheses.
Background on certainty domains and common sources of uncertainty in evidence assessment.
Canadian public trial-discovery context; registry information may be delayed or link to external records.
Peptide Index does not diagnose, interpret personal health information, recommend testing or treatment, set targets, recommend dosing, verify product quality, or make a purchase recommendation. Where direct evidence is incomplete, the platform states that limit instead of converting uncertainty into a claim.
Read Editorial Standards🔗 More tools, guides, vendor links, and resources below ↓
